Defense Advanced Research Projects AgencyTagged Content List

Threat Countermeasures

Actions that mitigate adversaries' capabilities

Showing 33 results for Countermeasures + News RSS
The rapid evolution of small unmanned air systems (sUAS) technologies is fueling the exponential growth of the commercial drone sector, creating new asymmetric threats for warfighters. sUASs’ size and low cost enable novel concepts of employment that present challenges to current defense systems. These emerging irregular systems and concepts of operations in diverse environments require technology advancements to quickly detect, identify, track, and neutralize sUASs while mitigating collateral damage and providing flexibility to operations in multiple mission environments.
A new DARPA program could help unlock the potential of advanced gene editing technologies by developing a set of tools to address potential risks of this rapidly advancing field. The Safe Genes program envisions addressing key safety gaps by using those tools to restrict or reverse the propagation of engineered genetic constructs.
It may not be obvious to humans, but the life of a plant is full of peril. Viruses, pests, fungi, herbicides, drought, pollution, salinity, flooding, and frost—the plants that we depend on for food, clean air, and materials are challenged by myriad threats, natural and man-made. By extension, human populations are put at risk when food security is challenged and the agricultural underpinnings of our economies are destabilized, especially when threats emerge rapidly or unexpectedly.
DARPA’s Anti-Submarine Warfare (ASW) Continuous Trail Unmanned Vessel (ACTUV) program has developed and built a technology demonstration vessel that is currently undergoing open-water testing off the coast of California and recently set sail with its first payload: a prototype of a low-cost, elevated sensor mast developed through the Agency’s Towed Airborne Lift of Naval Systems (TALONS) research effort.
Over the past several years, DARPA-funded researchers have pioneered RNA vaccine technology, a medical countermeasure against infectious diseases that uses coded genetic constructs to stimulate production of viral proteins in the body, which in turn can trigger a protective antibody response. As a follow-on effort, DARPA funded research into genetic constructs that can directly stimulate production of antibodies in the body